Tuesday, February 18, 2020

Care providers use the knowledge gap about ME/CFS as an excuse for indolence

  • February 2020 
  • Läkartidningen 117(8):FY3L

    • Sten Helmfrid
      Sten Helmfrid
    • Sture Eriksson
      Sture Eriksson
    • Abstract

      Care providers use the knowledge gap about ME/CFS as an excuse for indolence. In spite of differences of opinion among researchers on the significance of reported physiological abnormalities, studies support the existence of a severely debilitating syndrome, independent of geography and with a distinct pattern of symptoms. Even though there is no specific treatment; patients need help with diagnosis, symptom relief and support measures. A recent official Swedish report concludes that this is best done at specialist clinics.
      When myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) gets media atten-
      tion, the lack of knowledge of the underlying pathology and the disagreements within
      the medical community are often emphasized.1,2 Care providers use the knowledge gap
      as an excuse for indolence.3 It is therefore important to point out that there is much that
      the researchers actually agree on and that the care of this neglected group of patients
      has to improve.
      ME/CFS was first observed as a sequel to certain infections.4,5 The cardinal symptom is
      post-exertional malaise (PEM).6 This can be described as a significant fatigability and
      symptom exacerbation after physical or cognitive activity, which often sets in with a de-
      lay. Other key symptoms are fatigue that is not relieved by rest, unrefreshing sleep, and
      neurocognitive impairment (e.g. concentration problems, short-term memory loss, and
      difficulty processing information). Most patients also show an array of autonomic, im-
      mune, and endocrine symptoms; as well as pain.7 The illness is recognized by the World
      Health Organisation (WHO) since 1969.8
      ME/CFS is not a socially transmitted illness, nor is it limited to western societies. The
      illness has been found in all places where it has been looked for: all social groups, all
      ethnic minorities, and all geographical regions.9-14 Studies show that ME/CFS often is
      severely debilitating,15-19 which is also acknowledged by clinicians and scientists working
      with this group of patients.20 The illness has an alarming tendency to become chronic,21,22
      although the prognosis for children and adolescents seems to be better.23,24 In 70–80 per-
      cent of the cases, the illness is triggered by an infection.25-28 However, there are other
      triggers, and the onset may also be gradual.29 It is well documented that some pathogens
      carry a high risk for developing ME/CFS, for example Epstein–Barr virus.30-34
      Physiological abnormalities have been reported in a number of studies, but there is a
      difference of opinion about the significance of the findings and there is no clear under-
      standing of the pathology. Some examples of findings that might provide valuable clues
      to what is going on are functional, chemical, and structural abnormalities in brain
      scans,35-42 impaired NK cell cytotoxicity,43 signs of autonomic44 and mitochondrial dys-
      function,45-47 and an unknown, soluble factor in the blood serum of patients that has
      affected the results of several studies.48-52 Physiological abnormalities and impaired cog-
      nitive performance have also been observed after exertion, which suggests that PEM is
      an objective phenomenon.53-58
      The controversy surrounding ME/CFS has mostly been about a treatment model, which
      is based on the assumption that the illness is perpetuated by unhelpful beliefs and de-
      conditioning. The model has been tested in a number of treatment studies, which have
      shown modest improvements in subjective outcomes.59 However, the results are dismis-
      sed by many researchers, as no improvement has been demonstrated in objective out-
      comes and the treatment effects do not exceed what could be expected from systematic
      bias.60-63 A recent review concluded that there is little scientific support for the model.64
      There has also been a difference of opinion about the diagnostic criteria. British psychi-
      atrists tried to redefine ME/CFS as idiopathic chronic fatigue,65 a proposition that has
      been dismissed by other scientists.66 There is some uncertainty about how a distinct clin-
      ical entity should best be defined, and several different diagnostic criteria have been
      proposed.67 However, this uncertainty does not invalidate the phenomenon ME/CFS.
      It is not acceptable to refer patients with ME/CFS to the Swedish primary care, where
      many GPs openly question the legitimacy of the diagnosis.3,68 Granted, there is no spe-
      cific treatment available, but the patients still need a thorough diagnosis, symptom relief
      and supportive care.69-71 A recent report published by the Swedish Agency for Health
      Technology Assessment and Assessment of Social Services (SBU) concluded that this can
      best be accomplished by specialist clinics,72 which so far only are available in a few pla-
      ces. The Swedish Counties must take a greater responsibility for this group of patients
      and provide specialized care. ME/CFS exists and the problem will not disappear.


    Monday, February 10, 2020

    First transferable factor in #MEcfs blood?


    »We could have our first transferable factor in #MECFS blood« Big news from Prusty Lab at University of Würzburg! But they need financial resources to continue their great work. Now we all can help them out together! Retweets appreciated! #GOfundMECFS bit.ly/gofundmecfs

    Dr. Prusty believes that a viral infection is disturbing mitochondrial function in #MECFS via blood factors and wants to investigate this. Read more here: https://www.gofundme.com/f/gofundmecfs-support-scientific-research-mecfs?


    Related Posts with Thumbnails